Effective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. It is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. The following links and documents on this page are intended to assist licensees who prescribe controlled medications by referencing resources and information that can be use in their practice. Board Rule Ch. 21 Use of Controlled Substances for Treatment of Pain (DOC) 36. Is Gabapentin a Controlled Substance in Tennessee and does it require a DEA to prescribe? Gabapentin is a Schedule V Controlled Substance in Tennessee and therefore should be treated just like any other Schedule V Controlled Substance. 37. I suspect my healthcare practitioner is engaged in TennCare fraud, waste, or abuse. What do I do? In the state of Kentucky, prescribers without a DEA license are unable to prescribe gabapentin after it was classified as a Schedule V controlled substance. 38 This licensing requirement is part of the state’s Controlled Substances Act which had the greatest impact on mid-level practitioners who may not have a DEA license. Kentucky Gabapentin isn’t a controlled substance according to the federal government. But several states have passed their own laws classifying gabapentin a schedule V (schedule 5) controlled substance. Combining gabapentin and opioids can be extremely dangerous. Please visit the Maine Data Hub for data and reports about substance use disorder in Maine or email PMPM for other PMP related data requests. Prescription Monitoring Program 207-287-2595, Option 2; TTY: Maine Relay 711; Fax: 207-287-4334; Email: PMP@maine.gov; Recent News. Newsletter - March 2023 (PDF) Prescribers and dispensers required to check prescription monitoring information. 22 §7254. Exemption from opioid medication limits until January 2017; rulemaking. The Revisor's Office cannot provide legal advice or interpretation of Maine law to the public. If you need legal advice, please consult a qualified attorney. Discover the current status of gabapentin scheduling as a controlled substance across the US and the PDMP requirements for each state. Valuable insights for healthcare providers. The number of individuals who have Gabapentin present in an accidental overdose is significant enough . to add Gabapentin dispensation into the CPRMS. Note: The Department is not changing the controlled substance scheduling of Gabapentin at this time. As such, the CPMRS look-up requirements do not apply to Gabapentin prescribing. Naloxone Gabapentin is classified as a controlled substance in several states due to its potential for misuse and abuse. Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. Title 17-A, §1102 Schedules W, X, Y and Z. I. Unless listed or described in another schedule, any compound, mixture or preparation containing narcotic drugs in any quantity, including, but not limited to, the following narcotic drugs or their salts, isomers or salts of isomers: heroin (diacetylmorphine); methadone; methadone hydrochloride; levo-alpha-acetyl-methadol, or LAAM; pethidine; opium 1. Controlled substance. "Controlled substance" means a controlled substance included in schedules II, III, IV or V of 21 United States Code, Section 812 or 21 Code of Federal Regulations, Section 1308. [PL 2023, c. 544, §1 (AMD).] 1-A. Acute pain. "Acute pain" means pain that is the normal, predicted physiological response to Except as provided in subsection 2, a person is guilty of unlawful possession of a scheduled drug if the person intentionally or knowingly possesses what that person knows or believes to be a scheduled drug, which is in fact a scheduled drug, and the drug is: A. single substance pharmaceutical exposures (i.e., the number of human exposure cases that identified only one substance), gabapentin was identified as a single substance in 6,955 cases in 2022. With respect to medical outcomes associated with gabapentin calls to poison control centers in 2022, gabapentin was associated with 6 deaths, 164 substances in accordance with the requirements outlined by the DEA and state of Tennessee. Prescriptions for Gabapentin dated on or after July 1, 2018, should be tr e ad s controlled sub stance prescriptions and contain all c on tr lled ub ance requirements listed above. Remember to review all controlled substance record keeping, inventory, Gabapentin is not a narcotic; however, according to the DEA, gabapentin has been increasingly documented as an illicit drug of abuse by police, in crime reports, and by U.S. poison control centers. Rates of diversion have also increased with gabapentin. The Maine PMP monitors all drugs in Schedules II, III, and IV, as described by the Federal Controlled Substances Act (CSA). How does Maine’s PMP work? Dispensers are required to submit information about dispensed controlled substances to Maine’s PMP, a secure online database, within one business day of dispensation. Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). At the national level, gabapentin is not classified as a controlled substance under the Controlled Substances Act (CSA). This means it is not subject to the stringent regulations that apply to opioids or benzodiazepines, which are categorized based on their potential for abuse, medical use, and safety.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | |